Glyoxal as an alternative fixative to formaldehyde in immunostaining and super‐resolution microscopy

Katharina N. Richter(Nanoscale Microscopy and Molecular Physiology of the Brain Cluster of Excellence 171 — DFG Research Center 103), Natalia H. Revelo(University of Göttingen), Katharina J. Seitz(University of Göttingen), Martin S. Helm(University of Göttingen), Deblina Sarkar(Human Media), Rebecca S. Saleeb(Heriot-Watt University), Elisa D’Este(Max Planck Institute for Biophysical Chemistry), Jessica Eberle(Max Planck Institute for Brain Research), Eva Wagner(Universitätsmedizin Göttingen), Christian Vogl(Universitätsmedizin Göttingen), Diana F. Lázaro(Universitätsmedizin Göttingen), Frank Richter(Universitätsmedizin Göttingen), Javier Coy‐Vergara(Universitätsmedizin Göttingen), Giovanna Coceano(Science for Life Laboratory), Edward S. Boyden(McGovern Institute for Brain Research), R. R. Duncan(Heriot-Watt University), Stefan W. Hell(Max Planck Institute for Biophysical Chemistry), Marcel A. Lauterbach(Max Planck Institute for Brain Research), Stephan E. Lehnart(Universitätsmedizin Göttingen), Tobias Moser(Universitätsmedizin Göttingen), Tiago F. Outeiro(Universitätsmedizin Göttingen), Peter Rehling(Universitätsmedizin Göttingen), Blanche Schwappach(Universitätsmedizin Göttingen), Ilaria Testa(Science for Life Laboratory), Bolek Zapiec(Max Planck Research Unit for Neurogenetics), Silvio O. Rizzoli(Nanoscale Microscopy and Molecular Physiology of the Brain Cluster of Excellence 171 — DFG Research Center 103)
The EMBO Journal
November 16, 2017
Cited by 336Open Access
Full Text

Abstract

Paraformaldehyde (PFA) is the most commonly used fixative for immunostaining of cells, but has been associated with various problems, ranging from loss of antigenicity to changes in morphology during fixation. We show here that the small dialdehyde glyoxal can successfully replace PFA Despite being less toxic than PFA, and, as most aldehydes, likely usable as a fixative, glyoxal has not yet been systematically tried in modern fluorescence microscopy. Here, we tested and optimized glyoxal fixation and surprisingly found it to be more efficient than PFA-based protocols. Glyoxal acted faster than PFA, cross-linked proteins more effectively, and improved the preservation of cellular morphology. We validated glyoxal fixation in multiple laboratories against different PFA-based protocols and confirmed that it enabled better immunostainings for a majority of the targets. Our data therefore support that glyoxal can be a valuable alternative to PFA for immunostaining.


Related Papers

No related papers found

Powered by citation graph analysis